Pacira BioSciences, Inc. - COM (PCRX)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
51M
Holdings value Q3 2024
$768M
Value change Q3 2024
-$173M
Grand Portfolio weight change Q3 2024
0%
Number of holders
232
Number of buys Q3 2024
128
Number of sells Q3 2024
-152
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 51M $768M -$173M $15.05 236
2024 Q2 51.9M $1.49B +$81.6M $28.61 276
2024 Q1 48.9M $1.43B +$10.9M $29.22 265
2023 Q4 48.3M $1.63B +$2.71M $33.74 254
2023 Q3 47.1M $1.44B -$16.6M $30.68 251
2023 Q2 46.9M $1.88B +$22.8M $40.07 250
2023 Q1 46.3M $1.89B -$75M $40.81 264
2022 Q4 48.3M $1.87B -$84M $38.61 265
2022 Q3 50.1M $2.66B +$46.6M $53.19 254
2022 Q2 48.9M $2.85B -$35.9M $58.30 271
2022 Q1 49.5M $3.78B -$46.5M $76.32 287
2021 Q4 50.6M $3.04B +$80.8M $60.17 262
2021 Q3 49.1M $2.75B -$7.66M $56.00 253
2021 Q2 49.2M $2.98B -$36.5M $60.68 254
2021 Q1 49.8M $3.49B -$29M $70.09 265
2020 Q4 50.3M $3.01B +$131M $59.84 257
2020 Q3 48.2M $2.9B -$13.4M $60.12 254
2020 Q2 48.7M $2.56B +$107M $52.47 241
2020 Q1 47M $1.57B +$37.7M $33.53 216
2019 Q4 45.5M $2.06B +$15.6M $45.30 228
2019 Q3 45.1M $1.72B +$75.4M $38.07 209
2019 Q2 42.8M $1.86B +$105M $43.49 216
2019 Q1 41.3M $1.57B +$29.4M $38.06 204
2018 Q4 40.1M $1.72B -$34.3M $43.02 201
2018 Q3 40.6M $2B -$82.3M $49.15 187
2018 Q2 42.9M $1.37B -$18M $32.05 151
2018 Q1 43.6M $1.36B +$18.7M $31.15 166
2017 Q4 41.9M $1.91B -$62.7M $45.65 182
2017 Q3 43.5M $1.64B +$58.8M $37.55 176
2017 Q2 41M $1.96B +$19.5M $47.70 190
2017 Q1 41.1M $1.87B +$212M $45.60 188
2016 Q4 39.9M $1.29B +$17.8M $32.30 177
2016 Q3 39.8M $1.36B -$42M $34.22 177
2016 Q2 40.7M $1.37B -$219M $33.73 183
2016 Q1 43.4M $2.3B -$44.9M $52.98 177
2015 Q4 43M $3.29B +$94.1M $76.79 211
2015 Q3 41.7M $1.71B -$35.6M $41.10 174
2015 Q2 42.8M $3.03B +$138M $70.72 186
2015 Q1 40.4M $3.59B +$93.1M $88.85 205
2014 Q4 39.2M $3.48B +$24.8M $88.66 199
2014 Q3 38.8M $3.76B +$100M $96.92 209
2014 Q2 37.8M $3.47B +$237M $91.86 191
2014 Q1 35.3M $2.47B +$15.2M $69.99 160